Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:04am EST - Canadian Markets open in 26 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Opexa Therapeutics, Inc. (OPXA)
On Feb 9:
1.95 USD
0.00 (0.00%)
MORE ON OPXA
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
Opexa Therapeutics, Inc.
(NCM:OPXA) Delayed quote data
Last Trade:
1.95 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
1.95
Open:
N/A
Bid:
1.85
x 2500
Ask:
2.09
x 100
1y Target Est:
8.00
Day's Range:
N/A - N/A
52wk Range:
0.25 - 6.93
Volume:
0
Avg Vol
(3m)
:
407,043
Market Cap:
25.17M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-1.91
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add OPXA to Portfolio
Download Data
HEADLINES
Traders Send Select Stem Cell Shares Soaring
Indie Research
(Mon, Feb 8)
Opexa to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2010
Business Wire
(Wed, Feb 3)
Slew of Stem Cell News Helps Sector Higher
Indie Research
(Mon, Jan 25)
Fat Gains for Select Stem Cell Stocks
Indie Research
(Fri, Jan 8)
Opexa Therapeutics, Inc. Announces Closing of $5.1 Million Registered Direct Offering
Business Wire
(Thu, Dec 17)
OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online
(Thu, Dec 17)
Opexa Therapeutics to sell $5.1 million in shares to investors
at bizjournals.com
(Thu, Dec 10)
Opexa Therapeutics, Inc. Announces $5.1 Million Securities Offering
Business Wire
(Thu, Dec 10)
OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat
EDGAR Online
(Thu, Dec 10)
Interim Data Lifts Geron, Stem Cell Rivals Mixed
Indie Research
(Tue, Dec 8)
More Headlines for OPXA...
ANALYST
EPS Est (next year)
(Dec-07)
:
N/A
EPS Est (in 2 years)
(Dec-08)
:
N/A
Avg Rec (current)*:
2.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Opexa Therapeutics, Inc., a development stage biopharmaceutical company, develops autologous cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular diseases.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices